Results 101 to 110 of about 22,786 (211)

Fluid/function correlation using AI‐based quantification versus central subfield thickness in treatment‐naïve and pre‐treated patients with neovascular AMD in a real‐world setting

Acta Ophthalmologica, Volume 104, Issue 3, Page 305-313, May 2026.
Abstract Purpose To investigate the association between best‐corrected visual acuity (BCVA) and quantitative macular fluid volumes, compared to central subfield thickness (CST) in treatment‐naïve and previously treated patients with active neovascular age‐related macular degeneration (nAMD).
Anna Eidenberger, Gregor S. Reiter, Virginia Mares, Sophie Frank‐Publig, Philipp Fuchs, Magdalena Baratsits, Markus Gumpinger, Georg Faustmann, Alexandra Miere, Catherine Creuzot‐Garcher, Ulrike Scheschy, Laurent Kodjikian, Vincent Gualino, Benjamin Wolff, Stefan Sacu, Ursula Schmidt‐Erfurth   +15 more
wiley   +1 more source

Aqueous humor cytokine levels in patients with subretinal fibrosis in neovascular age-related macular degeneration

BMC Ophthalmology
Purpose To investigate aqueous humor cytokine levels in neovascular age-related macular degeneration (nAMD) patients with subretinal fibrosis and to explore the relationship between cytokine levels and disease severity.
Ying Cao, Meijia Dang, Zhen Tian, Tiantian Zhang, Lihua Hou, Min Wang, Shuhui Xing, Yingni Huang, Jing Li   +8 more
doaj   +1 more source

Consensus on age‐related macular degeneration course curricula for general ophthalmologists and non‐ophthalmologist clinical staff: A Delphi study

Acta Ophthalmologica, Volume 104, Issue 3, Page e269-e276, May 2026.
Abstract Purpose To define the curriculum content for two interactive learning courses on age‐related macular degeneration (AMD): (1) an advanced course tailored for general ophthalmologists and (2) a basic course for non‐ophthalmologist healthcare staff.
Filip Sommer‐Lind, Yousif Subhi, Anna S. Vergmann, Monica Lövestam‐Adrian, Nis Andersen, Enrico Borrelli, Lasse J. Cehofski, Mads K. Falk, Øystein K. Jørstad, Kai Kaarniranta, Musa Y. Kaya, Morten B. Larsen, Gregor S. Reiter, Miklos Schneider, Henrik Vorum, Jakob Grauslund, VILMA‐AMD Study Group, Anja Bate, Anja Lund, Anssam Al‐Sharmary, Audrone Rimsaite, Charlotte Melsen, Charlotte Mikkelsen, Christoffer Rud Sørensen, Elizabeth Visby, Hanne Roed, Henrik Kemp, Henrik Melsom, Jeanet Lomholt, Jens Lundgaard Andresen, Jesper Skov, Karen Laursen, Kristian Lundberg, Lena Andersen, Lene Bang Jensen, Line Gerken, Line Petersen, Louise Munkholm, Marie Krogh, Mette Borg Madsen, Mikkel Lyngholm, Per Flesner, Pernille Oversø Hansen, Peter Fahmy, Sathuja Prasad, Søren Berndt Hansen, Søren Kromann Abildgaard   +46 more
wiley   +1 more source

Neovascular age‐related macular degeneration without drusen

Acta Ophthalmologica, Volume 104, Issue 3, Page e300-e311, May 2026.
Abstract Purpose To describe the clinical characteristics and 1‐year follow‐up of patients with neovascular AMD (nAMD) without drusen in either eye. Methods This is a multicentre retrospective cohort study in three tertiary referral centres in The Netherlands. We included patients of 55 years or older with nAMD in one or both eyes, without the presence
Marc J. Sirks, Elon H. C. van Dijk, Husein Ghalayini, Somayeh Bazdar, WeiFeng Yu, Suzanne Yzer, José P. Martinez Ciriano, Reinier O. Schlingemann, Roselie M. H. Diederen, Camiel J. F. Boon   +9 more
wiley   +1 more source

Evaluating Faricimab in Treatment-Naive Neovascular Age Related Macular Degeneration: A Retrospective Analysis of Real-World Data

Clinical Ophthalmology
Danielle Modeste,1 Christopher Stewart,2 Hajani Premanandhan,2 Mahmoud Husseiny Awad,1 Gwyn Samuel Williams1 1Ophthalmology, Singleton Hospital, Swansea Bay University Health Board, Swansea, Wales, UK; 2Swansea Bay University, Medical School, Swansea ...
Modeste D, Stewart C, Premanandhan H, Awad MH, Williams GS   +4 more
doaj  

Increased choroidal stromal volume and altered choriocapillaris perfusion in neovascular AMD: An SS-OCTA association study

Photodiagnosis and Photodynamic Therapy
Purpose: This study aimed to characterize quantitative choroidal metrics using swept-source optical coherence tomography angiography (SS-OCTA) across different stages associated with neovascular age-related macular degeneration (nAMD) and to identify ...
Xuelin Chen, Xuenan Zhuang, Guiqin He, Miaoling Li, Xiongze Zhang, Jiaxin Pu, Yuying Ji, Yining Zhang, Xinlei Hao, Feng Wen   +9 more
doaj   +1 more source

Switching to Faricimab or High‐Dose Aflibercept for Neovascular AMD in High‐Demand Patients: Impact on Injection Interval in a Real‐World Cohort

Clinical &Experimental Ophthalmology, EarlyView.
Zachary George Angus, Yin‐Zhi Lee, Sukhpal Singh Sandhu, Robyn Troutbeck, Jonathan Yeoh, Daniel Chiu, Manishka Jayasundera, Jaesser Tan, Sanjeewa Wickremasinghe   +8 more
wiley   +1 more source

Faricimab bei vorbehandelter neovaskulärer altersabhängiger Makuladegeneration (nAMD)

Die Ophthalmologie
Zusammenfassung Hintergrund Faricimab wurde als erster bispezifischer Antikörper 9/2022 zur Behandlung der neovaskulären altersabhängigen Makuladegeneration (nAMD) und einer Visusbeeinträchtigung infolge eines diabetischen Makulaödems oder eines retinalen Venenverschlusses in der EU zugelassen.
Britta Heimes-Bussmann, Rooschanak Bellenbaum, Christian Njoo, Sandra Liakopoulos, Steffen Schmitz-Valckenberg, Max Zortel, Kai Rothaus, Jost Leemhuis, Peter Mussinghoff, Albrecht Lommatzsch   +9 more
openaire   +1 more source

Recent daily life burdens associated with neovascular age-related macular degeneration involve difficulties in use of electronic devices

Scientific Reports
Neovascular age-related macular degeneration (nAMD) is a prevalent cause of permanent vision loss and blindness in the elderly worldwide, with a significant impact on patients’ daily lives.
Yoko Ozawa, Keisuke Yoshihara, Marwa Mezghani, Paulina Pierzchała, Mateusz Nikodem, Sylvaine Barbier, Mariko Nomoto, Yasuko Aitoku   +7 more
doaj   +1 more source

Technik und Strategie der adjuvanten Radiotherapie bei nAMD

, 2017
Hintergrund: In der Therapie der neovaskulären altersabhängigen Makuladegeneration (nAMD) sind intravitreale VEGF-Inhibitoren die Therapie der ersten Wahl. Die Verbesserung der Prognose der AMD erfordert jedoch viele intraokulare Injektionen. Die theoretische Grundlage für eine mögliche[zum vollständigen Text gelangen Sie über die oben angegebene URL]
Rating, P, Freimuth, MA, Bornfeld, N
openaire   +2 more sources